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'[HE' term, chemotherapy of tuberculosis, implies a simplified concept which may
have been compromised in the reader's mind by the experience of, successful
chemotherapy in other fields. It is not a misplaced pedantry which leads clinicians
to speak of the "management" of tuberculosis, but rather a work-a-day
acquaintance and understanding of the many diverse pathological conditions
involved. The mechanical changes have links in common with those found in typhoid
fever, in schistosomiasis, in leprosy, and in syphilis. These basic facts were elicited
fifty years or more ago by some of the most remarkable pathological studies ever
reported, and there is a (langer which some see lurking in a certain neglect of these
lessons by those of us whose businiess it is to stucdy the chemotherapy of tuberculosis,
both experimentally and clinically. No other host-parasite relation has been the
subject of such detailed enquiry at thc hands of the pathologists (Rich, 1944), bac-
teriologists, chemists (Wells and Long, 1932; Anderson, 1932), and others. Appre-
ciation of the unusual pathology of this normally self-limiting chronic disease has
emphasised the desirability of approaching the problem of elimination of the
parasite on a broad front. It will be convenient for our present purpose first, to
point the nature of the biochemical lesions which the observed pathological changes
indicate, and from this basis, to review the present advances.
Usually, by the time the disease is identified clinically it has established its
characteristic pathology, the tubercle, and this is so even in tubercular meningitis
(Rich and McCordock, 1933). The minimal clinical lesion visualised, for example,
by X-ray shadows, represents destructive changes and reflects, as we shall see at
least two 'biochemical lesions.'
THE ORIGIN OF THE TUBERCLE AND ITS ULTIMATE FATE
Many studies of all stages of the development of tubercles enable an unequivocal
description to be given (Rich, ch. 18, 1944). Within a few minutes of an experi-
mentally-induced infection a normal mononuclear phagocyte ingests a (single)
invading tubercle bacillus. The cell increases in size, its nucleus enlarges, and it
becomes an epithelioid cell (Sabin and Doan, 1927). Next, fusion of several
epithelioid phagocytes takes place to give a Langhans giant cell, with its numerous
nuclei arranged in a 'rosette,' or there may be formed the less frequent 'foreign-
body giant cell' in which the nuclei are scattered. Within three or four days a small
nodule is built up by clustering epithelioid cells, shown by Metchnikoff (Soper,
1917) to be simply altered monocytes. Since the nodule grows progressively after
access to blood-borne phagocytes is cut off, it is believed (Rich, 1944) that multi-
plication of the phagocytes occurs in situ. Gradually the adjacent tissue cells are
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tubercle. At this stage of development collagen fibres, demonstrated by suitable
stains, are formed between the epithelioid cells. Should multiplication of the
bacillus be held in check no necrosis is observed, and with the death of the tubercle
bacilli, the transfer to collagen becomes progressive, the tubercle becoming fibrous,
so that only a nodule of fibrous tissue finally remains. Complete resolution and
disappearance of the tubercles has been frequently reported, and this is also true
of large tubercles which had proceeded to central caseation in guinea-pigs (Gardner,
1922). Should multiplication proceed, the central portion dies and becomes necrotic.
PERMEABILITY OF THE TUBERCLE
Important from any consideration of chemotherapy is whether tubercles and
associated caseous tissue are readily permeable. Rich (1944) points to the inherent
evidence of viable tubercle bacilli and host cells dependent upon diffusible nutrilites
for their continued survival, and to the frequency with which central foci become
calcified. Much additional evidence is now available from chemotherapeutic studies
with diaminodiphenylsulphone derivatives, such as promin (Feldman, Mann, and
Hinshaw, 1942), and sulphetrone (Brownlee and Kennedy, 1948), and of the positive
evidence of diffusibility derived from successful streptomycin therapy in miliary
tuberculosis of man (Baggenstoss, Feldman, and Hinshaw, 1947). Brownlee (1948)
has found sulphetrone to penetrate normal and caseous tissue of man with equal
facility.
HYPERSENSITIVITY AND NECROSIS
Although the death of host cells appears to follow to some degree the lodgment
of the foreign body which the tubercle bacillus also is, it is now known that the
widespread tissue destruction, which characterises the disease, follows the
conditioned hypersensitivity induced by the products of metabolism of virulent
pathQgens. The protein component is known to be responsible and appears to be
identical with tuberculin, which is harmless to the normal nonsensitised animal,
but is a deadly poison to the sensitised host. All that is known of this mechanism
confirms the opinion that the clinical disease in all its manifestations follows from
the phenomenon of hypersensitivity. Actively multiplying organisms appear to be
essential, and virulence in this connection connotes a capacity to multiply.
CASEATION
Liquefaction of body cells after their death is the normal prerequisite for disposal
by phagocytes and is a function of proteolytic enzymes identified in both host cells
and macrophages. In the characteristic tuberculous lesion partial autolysis only
occurs, so that the necrotic cells lose structure, outline, and nuclei to become,
together with their intercellular materials, a formless 'caseous' mass. Opinion is
divided on the reason for incomplete digestion. Opie and Barker (1914) showed that
active enzymic function could be identified with the onset of caseation, but
subsequently ceased, whether due to absence or inactivation, was not proved.
Jobling and Petersen (1914) found the soaps of unsaturated fatty acids extracted
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enzymes, and this inhibition was itself reversed by iodine. On the other hand,
caseation is characteristically observed in man in infections with micro-organisms,
which attract mononuclear phagocytes, for example, in typhoid fever, but not in the
allied colon bacillus infections which attract polyinorphonuclear phagocytes. It is
of great interest that typical caseation follows the necrosis of "lipoid pneumonia,"
which results from the accidental introduction of, for example, liquid paraffin or
cod-liver oil into the human lung. An outpouring of mononuclear phagocytes
characterises these lesions also (Rich, ch. 18, 1944). The predominance of mono-
nuclear phagocytes in caseous lesions induced the comparison of Weiss and
Czarnetzky (1935) between the proteolythic enzyme activity of the two types of
cells. The monocytes of rabbits contained one proteinase, pepsin, with an optimal
activity at pH3, whereas the polymorphonuclears contained pepsin, cathepsin, and
trypsin, with optima at pH3, 5.4, and 8 respectively.
SOFTENING
The 'softening' of caseous lung substance allows imprisoned tubercle bacilli to
be discharged into the air passages and thus to infect new sites. In contrast to
caseous areas, a remarkable characteristic of softened areas is the large number
of tubercle bacilli they coptain. It seems logical to attribute the lysis of caseous
material to enzymic action, but this is unproven. Tubercle bacilli are known to be
poor in proteolytic enzyme content (Wells and Long, 1932), and the current view
appears to attribute the renewed digestion to the activity of infiltrating polymorpho-
nuclear leucocytes, which are commonly identified in freshly softening areas
(Huebschmann, 1928; Rich, 1944).
FATE OF THE CASEOUS LESION
Should the tubercle bacilli die the caseous area may become encapsulated by
connective tissue, or it may be resolved. This surprising observation is now well
documented (Burke, 1922; Willis, 1934; Oppenheimer, 1935).
CALCIFICATION
The calcium phosphate, which is deposited in caseous areas, has the same
composition Ca, (PO4)2 as that of normal bone (Wells and Long, 1932) and, apart
from the suggestive indications that high serum calcium and phosphorus concen-
trations influence calcium deposition (Bullock, 1930), as, for example, in children,
generally, and that phosphatases (Bell, 1945) and Vitamins A. (Mellanby, 1944)
and D play an important, but as yet undisclosed part, no final comment may be
made on the conditions governing deposition of calcium in necrotic tissue.
MODE OF ACTION OF THE TUBERCLE BACILLUS
We are now in the position to examine three important biochemical reactions
conditioned by the host-parasite relation, and to enquire further into the activity
of the specific substances involved.
811. The bodies of infecting tubercle bacilli contain substances which resist
degradation by the ordinary defensive mechanisms and which are treated by the
host in an unusual way. Instead of beipg engulfed by polymorphonuclear leucocytes
and carried to the lymph nodes for digestion and elimination, they are absorbed
in sittu by monocytes which may subsequently be converted into a tubercle. It is
noteworthy that this is the beginning of a usually successful self-limiting process
and it is tempting to regard it as a protective device on the part of the host.
Numerous observers (Maximow, 1924; Rich, 1944) have been impressed enough
by the non-toxicity of multiplying virulent tubercle bacilli for normal tissue, or in
tissue culture preparations, to describe the association as symbiosis. Nevertheless,
the immunity of the bacillus within the monocyte and, should multiplication ensue,
the subsequent production of caseous tissue appear to indicate a common
biochemical lesion associated with specific enzyme inhibition.
2. The tubercle bacillus produces no pharmacological poison, either of exoto'xic
origin excreted during the life of the bacillus, or of endotoxic nature liberated
by lysis after its death. Should multiplication ensue, a product of metabolism
induces hypersensitivity of adjacent host cells, with the result that an otherwise
innocuous product becomes a poison responsible for the death of cells. This
remarkable host parasite collaboration is responsible for the majority of the clinical
manifestations of the disease.
3. During infection the host may develop a capacity to modify the course of the
disease-an acquired resistance.
'THE CHEMICAIL COMPOSITION OF TUBERCLE BACILLI AND THE
BIOLOGICAL ACTIVITY OF ITS COMPONENTS
Subsequent to the admirable summary of Wells and Long (1932) on the chemical
composition of tubercle bacilli, Sabin (1932) described the biological effects
produced by the lipoids fractionated by Anderson (1932) and his colleagues from
standard strains of acid-fast bacteria. These workers described three main
fractions: a 'phosphatide,' extracted by alcohol-ether, an acetone-soluble 'fat,' and
a chloroform-soluble 'wax.' The chloroform fraction is not a true wax, but is a
complex phosphatide of unusual composition. It yields numerous glycerides of
fatty acids of the phthioic acid series, together with phosphorus, glycerol, and
a polysaccharide. The acetone-soluble 'fat' contains neither phosphorus nor
nitrogen and yields a carbohydrate and numerous fatty-acids on hydrolysis. The
acids present are butyric, palmitic, stearic, cerotic, linoleic, linolenic, tuberculo-
stearic, and phthioic acids. The acetone fraction has proved to be the best source
for the characteristic fatty acids of the tubercle bacillus (Table I).
From the acid hydrolysis of the phosphatide has beeh obtained an analogue of
stearic acid C18H36 2 named tuberculostearic acid, subsequently shown by Spielman
to be 10-methylstearic acid, and was found by Sabin (1932) to be without biological
activity. There were also separated d- and 1- hexacosanic acids, C,H5H0,, named
phthioic acid, of which only the d- acid had biological activity (Sabin, 1932).
Analogous, but optically inactive, acids with biological activity (Sabin, 1932) were
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It seems likely that Anderson's 'phthioic acid' is a mixture, and Polgar and
Robinson (1945), after synthesising a number of methyl-substituted long-chain
acids and reviewing the chemical, physical, and biological evidence, expressed a
preference for 3: 13: 19-trimethyltricosanoic acid as 'phthioic acid.'
TABLE 1
Cleavage products from bacterial phosphatides
(From Anderson, 1932)
Human Avian Bovine Timothy Leprosy
Per Cent. Per Cent.Per Cent. Per Cent.Per Cent.
Total ether soluble - - - 66-67... 55-56... 57-58... 60 ... 62.2
Palmitic acid 30.5 ... 18.4 ... 27.0 ... 20.0 ... 18.6
Oleic acid after reduction to stearic acid 12.8 ... 18.4 ... 7.0 ... 5.-6 ... 13.8
Liquid-saturated fatty acids, presumably
mixtures of tuberculostearic and
phthioic acids - - - 20.9 ... 14.1 ... 16.0 ... 18.0 ... 13.5
Total fatty acids recovered - - 64.2 ... 53.7 ... 50.0 ... 43.6 ... 45.9
Water-soluble constitue,its - 33-34... 46-47... 43-44... 40.0 ... 38.0
Mannose - - - - 9.2 ... 13.3 ... 6.7 ... 9.5 ... 5.2
Inosite (inositol) - - - 8.9 ... 3.0 ... 3.5 ... 2.2 ... 0.6
Other Sugars - - - 12.3 ... - ... ... ... 20.6
Glycerophosphoric acid - - - 5.4 ... 6.0 ... 9.9 ... 10.0 ...
ACID-FASTNESS
A large group of organisms, of which the tubercle bacillus is one, resist
decolourisation with acids after dying with aniline dyes. This property is retained
by the 'waxy' phosphatide and of that complex by an acid of high molecular weight
named 'mycolic acid' (Anderson, 1932; Stodola, Lesuk, and Anderson, 1938).
Certain evidence points to the fact that the physio-chemical state of mycolic acid
within the bacillus contributes to acid-fastness (Benians, 1912; Sherman, 1913).
BIOLOGICAL PROPERTIES OF THE ISOLATED LiPOIDS
In the hands of Sabin and her colleagues (Sabin, Doan, and Forkner, 1930;
Sabin, Smithburn, and Thomas, 1935; Sabin, 1932) all three of Anderson's (1932)
lipoid fractions, but no other fraction, protein, or carbohydrate, produced
tubercles. Of these, phosphatide was most active in giving epithelioid, giant cells,
and subsequent caseation, and this applied to phosphatide from human, avian,
bovine, timothy grass, and lepra bacilli, in that order of biological activity (Sabin,
1932). The only other substance among the controls which 'acts just like the
tuberculo-phosphatide' (Sabin, 1932) is lecithin. Tuberculostearic acid wvas found
to be irritating, but did not produce tubercles. Dextrorotatory phthioic acid-but
not levorotatory-produces typical tubercles. Sabin (1932) has refuted the sugges-
tion of Boissevain and Ryder (1931) that bacillary debris accounted for the
phosphatide activity. Still others (Bloch, 1936) are critical of the specific activity
of the phosphatide being attributable to phthioic acid. Of more moment is the
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and of phthioic acid needed to produce tubercles and caseation compared with the
observable depredations of a single bacillus. For example, the phosphatide from
300 mg. of bacilli produced a little caseation in one of four guinea-pigs injected
intraperitoneally and in each of two receiving the amount from 8.0 grm. of bacilli
(Smithburn and Sabin, 1932). More recently Ungar, Coulthard, and Dickenson
(1948) found the synthetic 3: 13: 19-trimethyltricosanoic acid of Polgar and
Robinson (1945)-to be more active than crude d-rotatory phthioic acid from human
tubercle bacilli in the production of tubercle-like granulomata, which 'corresponded
in some respects to the description of Sabin, Doan, and Forkner.' Of fifteen
synthetic acids tested, ten were as active as or more active than the natural
product. The most active synthetic substance was 3: 12: 15-trimethyldocosanoic
acid, which showed granulomata with as little as 10 to 25 mg. in a single intra-
peritoneal dose suspended in watery alcohol. The surface layer of precipitated
phthioic acid analogues is no doubt very different from that of the continuous
film of the intact bacillus. Realization of this fact prompted Ungar (1949) to observe
the chemiotactic response of macrophages to agar blocks in which these acids were
entrained and then subsequently implanted in the peritoneal cavity of guinea.pigs.
The first cells to penetrate were polymorphonuclear leucocytes and lymphocytes;
then came monocytes, which engulfed the particles and became typical epithelioid
cells. The same worker has made some preliminary observations which, if
confirmed, will shed light on the quantitative aspect of the responses of phthioic
acid and its analogues. Ungar (1949) coated killed colon bacilli with 3: 13: 19-
trimethyltricosanoic acid-and injected the suspension intraperitoneally into
guinea-pigs; the subsequent granulomata of the omentum, and elsewhere, were
indistinguishable from those of killed tubercle bacilli simultaneously injected into
controls, and differed entirely from the minor reactions observed in control animals
injected with suspensions of colon bacilli.
BIOLOGICAL SIGNIFICANCE OF THE CARBOHYDRATES
The tuberculocarbohydrates isolated by Johnson, Coghill, Brown, and Renfrew
(from Sabin, 1932); the polysaccharides isolated from the lipoids by Anderson
(1932); and the carbohydrate isolated from media by Long and Seibert were studied
by Sabin (1932). Their biological activities appear to be restricted to a chemiotactic
and damaging effect on leucocytes. They have no power to induce hypersensitivity
(Sabin, Joyner, and Smithburn, 1938), but can act as haptens (Laidlaw and Dudley,
1925). That is to say, unlike the pneumococcus specific carbohydrate (Avery and
Gobel (1933); Felton (1938) ), the tuberculocarbohydrate does not stimulate antigen
formation or induce protection, but is capable of reacting in precipitin tests with
sera from infected hosts.
BIOLOGICAL SIGNIFICANCE OF THE PROTEINS OF THE TUBERCLE BACILLUS
A number of proteins have been extracted from the tubercle bacillus ond one
from the medium in which it is grown (Wells and Long, 1932). In their most pure
forms these proteins have practically no toxicity for the uninfected body (Seibert
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impure 'tuberculin' in extremely small doses for the tuberculous subject. The
innocuous nature of purified tuberculoprotein for non-sensitised cells was demon-
strated in an elegant way in tissue-culture preparations by Rich and Lewis (1932)
and contrasted with its lethal effect on similar cells from tuberculous hypersensitive
animals (Aronson, 1931; Moen and Swift, 1936). Thus, although innocuous for
the normal, it is highly toxic for the tuberculous hypersensitive body, causing
necrosis, fever, severe constitutional symptoms, and even death. These facts, first
demonstrated by Koch, have been repeated many times (Long and Seibert, 1926)
and have been redemonstrated in a most convincing fashion by Seibert (1941),
using 'pure' tuberculin. Thus, while hypersensitivity is demonstrably a response
to protein within the bacillus, no convincing evidence has been offered that this
hypersensitivity can be induced in the normal animal with the protein itself. Only
whole bacilli, living or dead, successfully initiate tuberculin hypersensitivity. The
tuberculoproteins are antigenic (Seibert, 1941; Deinnes, 1929; Pinner, 1928),
but they have no protective capacity.
ACQUIRED RESISTANCE
While infection with the tubercle bacillus does not confer the stable and solid
protection acquired after diphtheria or smallpox, there is little doubt that
a significant degree of protection is attained (Rich,1944). Although widespread
agreement exists that the living attenuated bovine bacillus of Calmette (1924),
BCG, confers recognisable acquired resistance in laboratory animals, there has
been more reluctance to accept the claims for heat-killed tubercle vaccine. A
meticulous and cr-itical reviewer like Rich, writing in 1944, speaks of the established
fact, doubted for years, and quotes numerous successful investigators (Boquet and
Laporte, 1937; Pagel, 1937; Thomas, 1933; Lange, Freund, and Jochimsen,1927),
yet Raffel (1946) is unable to satisfy himself that a heat-killed vaccine confers
resistance. In the writer's laboratory Brownlee and Kennedy (1949) found the
glycerol-killed vaccine of Griffith and Glover (1939) to be little less effective than a
BCG living vaccine.
ELIMINATION OF THE PARASITE-INDIIECT APPROACH
Attempts to demonstrate acquired resistance with BCG and killed vaccine in the
laboratory animal (Table 2) have probably also been successful for man (BCG,
Irvine, 1934) (killed vaccine, Kayne, 1936). However, no recombination of the
known chemical fragments has, as yet, proved successful. It appears that the
antigenic complex which confers resistance is labile and readily destroyed by
chemical manipulation. Renewed attempts, as, for example, by the extraction of
living cells with urea solutions, probably at low temperatures, appears justified.
The synthetic or semisynthetic approach may prove amenable, since the identi-
fication of the precise chemical causal agent associated with the biochemical lesion
observed in the tubercle may have already occurred in the substance at present
labelled 3: 13: 19-trimethyltricosanoic acid; but of greater significance is the
uncovering of synthetic analogues of enhanced biological activity.
85TABLE II
Immunological responses of guinea-pigs to an attenuated tubercle
bacillus, a tubercle vaccine, and its chemical fragments
Purified
Preparations Injected Acquired Tuberculin Biochemical Lesions
Resistance Associated With Responses
1. BCG - - - + ... + ... Acquired resistance
Chemiotaxis of monocytes
Inhibition of proteases
Hypersensitivity effect
Skin allergy
2. Suitably prepared
vaccine - - + ... + ... as 1 above
3. 'Wax't - - + t ... Chemiotaxis to monocytes
Inhibition of proteases
Skin allergy
4. Phosphatide - - ... as 5 below
5. 'Phthioic acid' - - - ... Chemiotaxis to monocytes
Inhibition of proteases
6. Crystalline Protein - ... ... Hypersensitivity lethal
collaboration
7. Polysaccharide - - - ... - ... Chemiotaxis of leucocytes
t 'Wax' contains bound protein
ARTIFICIAL ANTIGENS
Not only may the specific acids, protein and carbohydrate, of the parasite be
recombined, but they may be linked, individually or in combination, to antigenically
significant proteins, with the object of improving upon the natural antigen which
confers active resistance. In these reactions, not only the protein carrier, but the
nature of the chemical linkage has proved significant.
In the writer's laboratory Brownlee and Friedmann (1949) prepared artificial
antigens from oleic, palmitic, stearic, 'phthioic acid,' and 'total phthioic-like acids.'
Well-defined crystalline azides were obtained with stearic and palmitic acids and
these were coupled to horse-serum globulin and to the high-sugar fraction of
albumen (Hewett, 1937), and, also for obsorption tests, to gelatine. While the
complexes were antigenic they retained no hapten specificity. Oleic acid, 'phthioic
acid' and 'total phthioice-like acids' did not give identifiable azides, but gave
complexes by coupling their acid chlorides to the same protein carriers at an
alkaline pH. Of these, probably only the 'total phthioic-like acids' and oleic acid
-retained hapten specificity and oleic acid was best.
Four of these antigens, BCG living vaccine, H37RV glycerol-killed vacc:ine,
oleic acid-globulin, and 'total phthioic acid-like acids' formed the basis of a guinea-
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bacillus, 'Carstars'-H37RV was deliberately avoided-which gave an average
infected life of thirty weeks in the control animals. The final basis of comparison
was a 'tuberculosis index' (Brownlee and Kennedy, 1948) based upon the distri-
bution of the disease in affected organs, and its histological significance in addition
to factors like duration of infected life. The artificial antigens were without
protective action, while the BCG and the glycerol-killed H37RV vaccine conferred
similar and significant resistance.
The possibility of interference with essential metabolites or growth factors on
the basis of substrate competition is now well appreciated (Woods, 1940; Fildes,
1940), but the possible intervention of antibodies raised in vivo in response to
artificial antigens containing the metabolite as hapten, is an alternative weapon.
With the starting point of phthiocol, the yellow pigment of human tubercle
bacilli (Anderson and Newman, 1940); Brownlee and Friedmann (1947), prepared
albumen, globulin, gelatine, and egg-albumen antigens to a series of twelve
synthetic analogues of phthiocol. Hapten specificity was probably never encountered
in this series and no compound was subjected to animal protection experiments.
'PROTECTIVE CAPSULE'-DIRECT APPROACH
The slow growth of the tubercle bacillus, its marked hydrophobic properties,
and its persistence in the host has raised a concept of a continuous protective
lipoid capsule (Rich, 1944; Wells and Long, 1932). Yet, after a first isolation on
an egg-enriched medium, freshly isolated tubercle bacilli grow on a simple medium
containing glycerol as a carbon source, asparagine as a source of nitrogen, phos-
phates, and a magnesium salt. Inexacting in its nutritional requirements, the adapted
organism appears to restrict its growth factors to magnesium and phosphorus,
which, together with an alcohol and an aliphatic amino-acid (amide), water and
oxygen, constitute its needs, all readily diffusible water-soluble substances of poor
lipoid solubility. There is, however, little doubt that the lipoid-protein carbohydrate
complex constituting the cytoplasmic matrix is capable of resisting the' passage
of quite simple ions into the cell, since the tubercle bacillus maintains its internal
environment within a very broad range of acidity and basicity (Richardson, Shoor,
and Loebel, 1931). Contact with 10 per cent. sulphuric acid for an indefinite period
does not kill; 18 per cent. hydrochloride acid kills in five hours, and 1 per cent. in
twenty-four hours; while 6 per cent. acetic acid kills. in less than thirty minutes
(Guss and Kloetzel, 1948). Equally impressive concentration of bases are required
to kill; 32 per cent. Na OH in twenty-four hours, or 40 per cent. for four hours.
Barium and calcium hydroxide similarly are non-lethal. Phospholipoids inhibit the
toxic action of many antiseptics upon bacteria, for example, small amounts of
cephalin protect Gram-positive bacteria against gramicidin in vitro, and in vivo
also, histones or protamines are able to combine chemically with active groupings
of the lipoid complex of Gram-negative bacilli and thus render them susceptible
to tyrothricin or typical detergents, which are otherwise inactive in these conditions
(Dubos, 1945).
87CHEMOTHERAPEUTIC SCREENING
In 1932 Long and Wells assembled the existing knowledge of chemotherapy of
tuberculosis and concluded that no known remedy modified the disease in the
experimental animal or man. These authors concluded: "A specific chemotherapy
of tuberculosis has not been found and it may be a long time in coming, because
of the inherent difficulties of the problem, but it is not a closed chapter. We have
some definite facts to go on, and some glimpses of light have been seen. Probably
some new success with some other bacterial infection will be needed to stimulate
a new attack on the more difficult problem offered by tuberculosis." Domagk's
(1935) very great discovery of the chemotherapeutic activity of prontosil rubum
against experimental infections due to virulent streptococci provided the new
impetus. The discovery and evaluation of the chemotherapeutic activity of
diaminodiphenylsulphone (Buttle, Stephenson, Smith, Dewing, and Foster, 1937)
and the demonstration of its high antibacterial activity to tubercle bacilli by Rist
(1939) provided the next step. The chronic toxicity of the parent substance (note,
not its insolubility, for toxic blood levels are only too readily obtained) prompted
the preparation of weighted derivatives. Promin, sodium p,pl-diaminodiphenyl-
sulphone-N,N'-didextrose sulphonate gave more encouraging results in guinea-
pigs than hitherto observed (Feldman, Hinshaw, and Moses, 1940), but clinical
studies were disappointing. Of a series (Feldman and Hinshaw, 1943; Smith,
Emmant, and Westfall, 1942), disodium formaldehyde sulphoxylate diaminodi-
phenylsulphone, diazone (Calloman, 1943), and 4,21-diaminophenyl-5'-thiazole-
sulphone, promizole (Feldman, Hinshaw, and Mann, 1944) were carried to clinical
trial, and the latter is still under observation. Sulphetrone, 4,41-bis (y-phenyl-n-
propylamino) disphenylsuiphone-tetrasodium sulphonate proved to be comparable
in activity to promin in the guinea-pig (Brownlee and Kennedy, 1948), and
remarkably free from chronic toxicity (Brownlee, Green, and Woodbine, 1948).
Applied to man it may have a use in certain forms of exudative tuberculosis of the
lungs (Anderson and Strachan, 1948; Madigan, 1948; Clay and Clay, 1948), but
its final status is unknown. It is synergic in action with streptomycin (Brownlee
and Kennedy, 1948), combined therapy, with which shows promise in miliary
tuberculosis, and tubercular meningitis (Madigan, Swift, Brownlee, and Wright,
1947). Sulphretrone appears to be the most useful chemotherapeutic agent at
present known in the allied acid-fast organism disease, leprosy (Muir, 1948).
The chemotherapeutic sulphones appear to owe their mode of action to substrate
competition, since their activity is inhibited by p-aminobenzoic acid. Lehmann's
introduction of 4-aminosalicylic acid to tuberculosis (Lehmann, 1946) deserves
special attention, since it illustrates the successful use of a metabolic approach.
He repeated the observation of Bernheim that benzoates and salicylates increased
the oxygen uptake of tubercle bacilli and noted that this was a feature of patho-
genic strains only. On the assumption that benzoates or salicylates might be active
as essential metabolites, Lehmann sought for competitive inhibitors. Of fifty benzoic
acid derivatives examined by microrespiration methods, 4-aminosalicylic acid
(p-aminosalicylic acid, P.A.S.) proved the most effective in inhibiting catabolic
oxygen utilization.
88ANTIBIOTICS
Streptomycin is the most effective known chemotherapeutic agent for the control
of experimental tuberculosis in the experimental animal, which infection it will
almost completely suppress under favourable conditions (Feldman, Hinshaw, and
Mann, 1945). Two biologically active streptomycins have been isolated from the
product of active strains. The substance formerly known as streptomycin A, and
representing the major constituent, is properly called streptomycin. It is N-methyl.-
L-glucosaminido-streptosido-streptidine. The minor component is mannosido-
streptomycin, formerly called streptomycin B. It is represented as d-mannosido-
N-methyl-L-glucosaminido-streptodido-streptidine; a 'streptomycin residue' is also
recognised which has antibiotic and enhancement properties (Waksman, 1948).
The exact structure of streptomycin, designated N-methyl-L-glucosaminido-
streptosido-streptidine of molecular formula C2H3N7012 is unknown. Hydrolysis
yields biologically inactive streptidine C8H,8N*O0 and streptobiosamine Cl3 239
Streptomycin has an established place in clinical tuberculosis.
Dihydrostreptomycin prepared by catalytic reduction of streptomycin has
significantly less neurotoxicity (Donovick and Rake, 1947), is equally effective with
streptomycin in experimental tuberculosis, is tolerated in patients hypersensitive
to streptomycin, and causes neurotoxicity more slowly and with higher doses.than
does streptomycin; moreover it appears equally effective in man (Hobson,
Tompsett, Musehenheim, and McDermott, 1948).
INOSITOL, STREPTOMYCIN, AND LIPOSITOL
Inositol occurs naturally in high concentration in-brain and heart muscle of
higher animals; it is an essential growth factor for a fungus, Nematospora
gossypii (Buston and Pramanik, 1931), a metabolite associated with Bios I of
yeasts (Eastcott, 1928), and a nutritional factor associated with alopecia in a strain
of mice (Woolley, 1941), but it is not at present known as a nutritional require-
ment for any bacteria (Knight, 1945). A diverse range of bacteria synthesise
inositol, including some associated with intestinal biosynthesis, as do also acid-
fast organisms like the tubercle bacillus of human, bovine, and avian origin, the
timothy grass bacillus, and the leprosy bacillus. There is an interesting difference
between the inositol content of Gram-negative (and possibly Gram-positive)
organisms which contain from 0.09 to 0.17 per cent., and the tubercle bacillus
which synthesises from 3 to 9 per cent. of inositol. Anderson and his colleagues
(Anderson, 1932) found inositol among the cleavage products of the phosphatides,
in which it fulfilled the function of the nitrogen-containing complexes of the more
usual phosphatides of higher plants and animals. By alkaline saponification of the
phosphatide he isolated maninositose of which the cleavage products were mannose
and inositol. A reference to the known cleavage products of streptomycin discussed
earlier in this review shows that streptidine may be regarded as a substituted
inositol linked, it is thought, through an ether linkage to a novel sugar. A third
interesting finding which appears to relate the three observations is the demon-
stration that lipositol from brain and soya bean competitively inhibits the anti-
89bacterial Gram-negative action of streptomycin. Lipositol from the latter source
was very active, so that one part inhibited three-hundred parts of streptomycin.
In 1942 Folch and Woolley showed brain phosphatide to contain inositol, and
subsequently the inositol-containing component, to which the name lipositol was
given, was thought to have an inositol-galactose structure.
CALCIFEROL AND LuPus
It was first observed clinically that cutaneous tuberculosis responded to the oral
administration of calciferol, vitamin D2 (Dowling and Thomas, 1945; Charpy,
1945). A suppressive effect upon experimental tuberculosis in guinea-pigs is claimed
(Raab, 1947), with an additional observation that 'inactivated' ergosterol, in
larger doses, gave a superior effect. It is clearly desirable to attempt to identify
the active substance in man and in the animal, and a study of excretory products
might be expected to throw light on the problem. In another connection it has been
found that feeding the allied molecule cholesterol to rats resulted in the excretion
of fatty acids of empiric formula C25H5002 (Cook, Polgar, and Thompson, 1948)
similar to the 'phthioic' acids already discussed.
EPILOGUE
The chemotherapeutic success in the field of allied diseases which Wells and
Long prophetically expected to stimulate the more exacting attack on the tubercle
bacillus has proved effective. Three, more or less, effective chemotherapeutic
agents are in use, and an increasing number of effective antibiotics and synthetic
chemotherapeutic drugs may confidently be expected.
The object qf the direct approach to the chemotherapy of tuberculosis has been
simply stated as 'the elimination of the parasite.' This simplification may falsify
the clinical status by reason of the morbid anatomy of the- disease. Stress has been
laid, therefore, on those pathological conditions which make tuberculosis a special
problem. In addition, the slow metabolism of the causal parasite endows it with
a capacity to survive unfavourable environments. Viewed in this light the new
effective chemotherapeutic agents may be expected to make a significant
contribution to the m.anagement of the disease and to find an ordered place in the
scheme of treatment.
The indirect approaches which have been indicated flow from the intensive
studies of the biochemical lesions caused by the clinical components of the causal
parasite, lipoids, carbohydrates, and proteins. It has been noted that the labile
substance responsible for acquired resistance has not been isolated.
The protein component does not appear to have attracted the attention it may
deserve, since the evidence appears complete that this substance is directly
responsible for the host-parasite collaboration which results in hypersensitisation
and death of the host's tissue. A chemical attack directed towards the pharma-
cological neutralization of this protein in vivo appears to offer a novel approach.
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